Search Within

William Pao

Formats
  1. Journal Article (78)
  2. Meeting Abstract (61)
  3. Book Section (1)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (98)
  2. Solid Tumor Oncology Division (97)
  3. Thoracic Oncology (89)
  4. Department of Pathology and Laboratory Medicine (72)
  5. GSK Faculty (72)
  6. Human Oncology and Pathogenesis Program (66)

More Groups

People
  1. Mark Kris (76)
  2. Vincent Miller (65)
  3. Marc Ladanyi (64)
  4. Gregory Riely (60)
  5. Maureen Zakowski (51)
  6. Valerie Rusch (34)

More People

Years
  1. 2017 (1)
  2. 2012 (1)
  3. 2011 (7)
  4. 2010 (15)
  5. 2009 (27)
  6. 2008 (19)

More Years

Publications
  1. Journal of Clinical Oncology (32)
  2. Clinical Cancer Research (21)
  3. Journal of Thoracic Oncology (17)
  4. Cancer Research (9)
  5. Modern Pathology (5)
  6. Proceedings of the National Academy of Sciences of the United States of America (5)

More Publications

Publishers
  1. American Association for Cancer Research (32)
  2. American Society of Clinical Oncology (32)
  3. Elsevier Inc. (18)
  4. Nature Publishing Group (8)
  5. Public Library of Science (6)
  6. Elsevier Science, Inc. (5)

More Publishers

Results (141)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors
    Journal Article

    Chitale, D.; Gong, Y.; Taylor, B. S.; Broderick, S.; Brennan, C.; Somwar, R.; Golas, B.; Wang, L.; Motoi, N.; Szoke, J.; more...
    Oncogene (2009)

    Fulltext@MSK | Save
  • Acquired resistance to epidermal growth factor receptor (EGFR) kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Bean, J.; Riely, G. J.; Balak, M.; Marks, J. L.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Lack of efficacy of erlotinib in most EGFR mutated non-small cell lung cancers (NSCLCs) with acquired resistance to gefitinib
    Meeting Abstract

    Costa, D. B.; Cho, B. C.; Sequist, L. V.; Riely, G. J.; Halmos, B.; Kim, J.; Huberman, M. S.; Pao, W.; Tenen, D. G.; Kobayashi, S.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma
    Meeting Abstract

    Riely, G. J.; Kris, M. G.; Marks, J. L.; Li, A.; Chitale, D. A.; Riedel, E. R.; Hsu, M.; Pao, W.; Miller, V. A.; Ladanyi, M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Mutations in the EGFR kinase domain mediate Stat3 activation via IL-6 production in human lung adenocarcinomas
    Meeting Abstract

    Gao, S. P.; Mark, K. G.; Leslie, K.; Pao, W.; Motoi, N.; Gerald, W. L.; Travis, W. D.; Bornmann, W.; Veach, D.; Clarkson, B.; more...
    Cancer Research (2008)

    Fulltext@MSK | Save
  • An integrated analysis of gene expression, copy number alterations, and kinase pathway mutations in lung adenocarcinoma reveals frequent loss of the MAPK phosphatase Gene DUSP4 in EGFR mutant tumors
    Meeting Abstract

    Chitale, D.; Gong, Y.; Broderick, S.; Brennan, C.; Taylor, B. S.; Somwar, R.; Wang, L.; Motoi, N.; Szoke, J.; Sander, C.; more...
    Laboratory Investigation (2008)

    Fulltext@MSK | Save
  • An integrated analysis of gene expression, copy number alterations, and kinase pathway mutations in lung adenocarcinoma reveals frequent loss of the MAPK phosphatase gene DUSP4 in EGFR mutant tumors
    Meeting Abstract

    Chitale, D.; Gong, Y.; Broderick, S.; Brennan, C.; Taylor, B. S.; Somwar, R.; Wang, L.; Motoi, N.; Szoke, J.; Sander, C.; more...
    Modern Pathology (2008)

    Fulltext@MSK | Save
  • Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy
    Journal Article

    Yang, C. H.; Yu, C. J.; Shih, J. Y.; Chang, Y. C.; Hu, F. C.; Tsai, M. C.; Chen, K. Y.; Lin, Z. Z.; Huang, C. J.; Shun, C. T.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma
    Journal Article

    Riely, G. J.; Kris, M. G.; Rosenbaum, D.; Marks, J.; Li, A.; Chitale, D. A.; Nafa, K.; Riedel, E. R.; Hsu, M.; Pao, W.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Genetic predictors of MEK dependence in non-small cell lung cancer
    Journal Article

    Pratilas, C. A.; Hanrahan, A. J.; Halilovic, E.; Persaud, Y.; Soh, J.; Chitale, D.; Shigematsu, H.; Yamamoto, H.; Sawai, A.; Janakiraman, M.; more...
    Cancer Research (2008)

    Fulltext@MSK | Save